Evaluation of the effects of serial phlebotomy on the transcriptome of major tissues and on the response to toxicants in rats

被引:4
作者
Blomme, Eric A. G. [1 ]
Ciurlionis, Rita [1 ]
Marsh, Kennan C. [2 ]
Waring, Jeffrey F. [1 ]
Yang, Yi [1 ]
机构
[1] Abbott Labs, Dept Cellular Mol & Exploratory Toxicol, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Dept Exploratory Kinet & Anal, Abbott Pk, IL 60064 USA
关键词
pharmacokinetic; bleeding; toxicogenomics; transcriptome;
D O I
10.1016/j.toxlet.2007.09.014
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Preclinical pharmacokinetic (PK) evaluations are typically conducted in rats before in vivo toxicologic evaluations. It is unclear how the serial bleeding procedures in PK studies affect tissue homeostasis or sensitivity to toxicity. In this study, our objective was to evaluate the impact of serial bleeding on the transcriptome of various major tissues (kidney, heart, liver, spleen) and their response to two well-characterized molecules, doxorubicin and cisplatin. Rats received single i.v. injections of saline, doxorubicin (8 mg/kg) of cisplatin (4 mg/kg). In each group, half of the rats were serially bled by tail vein. Serial bleeding was associated with slight decreases of red blood cell parameters, but did not result in histopathological changes or in increased sensitivity to doxorubicin and cisplatin toxicity based on clinical pathology and histopathology evaluation. In addition, serial bleeding did not induce significant gene expression changes in either vehicle- or compound-treated rats when compared to their respective control groups. Overall, these results suggest that the serial bleeding procedure used in PK studies in our institution minimally affects the tissue response to toxicants, and support the use of these studies to generate early toxicology data in drug discovery. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:138 / 148
页数:11
相关论文
共 32 条
  • [1] Identification of putative gene-based markers of renal toxicity
    Amin, RA
    Vickers, AE
    Sistare, F
    Thompson, KL
    Roman, RJ
    Lawton, M
    Kramer, J
    Hamadeh, HK
    Collins, J
    Grissom, S
    Bennett, L
    Tucker, CJ
    Wild, S
    Kind, C
    Oreffo, V
    Davis, JW
    Curtiss, S
    Naciff, JM
    Cunningham, M
    Tennant, R
    Stevens, J
    Car, B
    Bertram, TA
    Afsharil, CA
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2004, 112 (04) : 465 - 479
  • [2] Adriamycin-induced oxidative mitochondrial cardiotoxicity
    Berthiaume, J. M.
    Wallace, K. B.
    [J]. CELL BIOLOGY AND TOXICOLOGY, 2007, 23 (01) : 15 - 25
  • [3] CHRONIC EXPERIMENTAL IRON LOSSES IN RATS NOT LEADING TO OVERT IRON-DEFICIENCY - A MODEL FOR THE REGULATION OF THE WHOLE-BODY IRON BALANCE IN AN IRON-REPLETE CONDITION
    BHARGAVA, M
    GABBE, EE
    [J]. JOURNAL OF NUTRITION, 1984, 114 (06) : 1060 - 1069
  • [4] Breitenbach J., 2003, TOXICOL APPL PHARM, Patent No. 6.599,931
  • [5] The use and analysis of microarray data
    Butte, A
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (12) : 951 - 960
  • [6] Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury
    Chaiswing, L
    Cole, MP
    St Clair, DK
    Ittarat, W
    Szweda, LI
    Oberley, TD
    [J]. TOXICOLOGIC PATHOLOGY, 2004, 32 (05) : 536 - 547
  • [7] CHOPRA S, 1982, KIDNEY INT, V21, P54, DOI 10.1038/ki.1982.8
  • [8] MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data
    Doniger, SW
    Salomonis, N
    Dahlquist, KD
    Vranizan, K
    Lawlor, SC
    Conklin, BR
    [J]. GENOME BIOLOGY, 2003, 4 (01)
  • [9] FURUHAMA K, 1983, Journal of Toxicological Sciences, V8, P161
  • [10] FURUHAMA K, 1987, Journal of Toxicological Sciences, V12, P1